Muscle Cramp Pain Reliever
NDC 43689-0022, Causticum, Colocynthis, Cuprum Metallicum, Magnesia Phosphorica, Phytolacca Decandra, Rhus Tox, Stannum Metallicum, Veratrum Album, tablet, from The Magni Company.
- Product NDC
- 43689-0022
- Status
- Listed
- Labeler
- The Magni Company
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43689-0022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAUSTICUM12 [hp_X]/1
- CITRULLUS COLOCYNTHIS FRUIT PULP12 [hp_X]/1
- COPPER12 [hp_X]/1
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE12 [hp_X]/1
- PHYTOLACCA AMERICANA ROOT12 [hp_X]/1
- TOXICODENDRON PUBESCENS LEAF12 [hp_X]/1
- TIN12 [hp_X]/1
- VERATRUM ALBUM ROOT12 [hp_X]/1
Pharmacologic classes
Calculi Dissolution Agent [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43689-0022-2 | 43689002202 | 1 BOTTLE in 1 CARTON (43689-0022-2) / 125 TABLET in 1 BOTTLE (43689-0022-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43689-0022 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43689-0022 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43689-0022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.